Advertisement
Advertisement
ABT
Abbott Laboratories
87.54
USDSponsored
-1.92
-2.15%
May 04, 16:00 UTC -4
Closed
After-Market
87.68
+0.14
+0.16%
ABT Earnings Reports
Positive Surprise Ratio
ABT beat 29 of 41 last estimates.
71%
Next Report
Date of Next Report
Jul 15, 2026
Estimate for Q2 26 (Revenue/ EPS)
$12.65B
/$1.29
Implied change from Q1 26 (Revenue/ EPS)
+13.36%
/+13.16%
Implied change from Q2 25 (Revenue/ EPS)
+13.58%
/+2.38%
Abbott Laboratories earnings per share and revenue
On Apr 16, 2026, ABT reported earnings of 1.14 USD per share (EPS) for Q1 26, missing the estimate of 1.15 USD, resulting in a -0.45% surprise. Revenue reached 11.16 billion, compared to an expected 11.11 billion, with a 0.51% difference. The market reacted with a +0.36% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 24 analysts forecast an EPS of 1.29 USD, with revenue projected to reach 12.65 billion USD, implying an increase of 13.16% EPS, and increase of 13.36% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Stryker Corporation
Report Date
Apr 30, 2026 For Q1 26
Estimate
$3.01
Actual
$2.60
Surprise
-13.75%
Boston Scientific Corp.
Report Date
Apr 22, 2026 For Q1 26
Estimate
$0.79
Actual
$0.80
Surprise
+0.69%
GE HealthCare Technologies Inc. Common Stock
Report Date
Apr 29, 2026 For Q1 26
Estimate
$1.07
Actual
$0.99
Surprise
-7.55%
ResMed Inc.
Report Date
Apr 30, 2026 For Q3 26
Estimate
$2.82
Actual
$2.86
Surprise
+1.28%
Zimmer Biomet Holdings, Inc.
Report Date
Apr 28, 2026 For Q1 26
Estimate
$1.88
Actual
$2.09
Surprise
+10.99%
Baxter International Inc.
Report Date
Apr 30, 2026 For Q1 26
Estimate
$0.31
Actual
$0.36
Surprise
+15.87%
Bio-Rad Laboratories, Inc.Class A
Report Date
Apr 30, 2026 For Q1 26
Estimate
$2.00
Actual
$1.89
Surprise
-5.68%
Cerus Corp
Report Date
Apr 30, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.01
Surprise
+75.49%
Sundial Growers Inc. Common Shares
Report Date
Apr 29, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.04
Surprise
+12.85%
Evolus, Inc. Common Stock
Report Date
May 04, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.10
Surprise
+24.59%
FAQ
What were Abbott Laboratories's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Abbott Laboratories reported EPS of $1.14, missing estimates by -0.45%, and revenue of $11.16B, 0.51% above expectations.
How did the market react to Abbott Laboratories's Q1 2026 earnings?
The stock price moved up 0.36%, changed from $100.69 before the earnings release to $101.05 the day after.
When is Abbott Laboratories expected to report next?
The next earning report is scheduled for Jul 15, 2026.
What are the forecasts for Abbott Laboratories's next earnings report?
Based on 24
analysts, Abbott Laboratories is expected to report EPS of $1.29 and revenue of $12.65B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement